New York Senate Bill S08592

New York 2025-2026 Regular Session

• Introduced: 11/26/25
• Refer: 11/26/25
• Refer: 1/7/26

Caption

Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children; requires coverage for glucose monitoring devices for all sugar disorders.

Impact

The implementation of S08592 would have a substantial impact on health insurance policies across New York. By mandating coverage for continuous blood glucose monitors, the bill aims to reduce the financial burden on families dealing with diabetes management. This could lead to increased health outcomes for children with diabetes, ensuring they have the best tools available for self-monitoring and management, thereby potentially lowering long-term healthcare costs associated with diabetes complications.

Summary

Bill S08592 aims to amend the New York Insurance Law to require health insurance plans to provide coverage for continuous blood glucose monitors specifically for all children. The bill addresses a significant area of concern for families with diabetic children, ensuring that they have access to necessary equipment that can help manage diabetes effectively. This legislation reflects a growing recognition of the importance of advanced medical technologies in treating chronic conditions from an early age.

Contention

While the bill has significant support due to its potential benefits for children with diabetes, it may face contention from insurance providers concerned about the costs associated with expanding coverage to include continuous glucose monitoring devices. Opponents may argue that this requirement could lead to increased insurance premiums or challenges in the availability of coverage for other health issues. Thus, balancing the need for this medical technology with insurance industry sustainability will be a critical point of discussion as the bill advances.